Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Chandima Jeewandara, Deshni Jayathilaka, Laksiri Gomes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
Chandima Jeewandara, Achala Kamaladasa, Pradeep Darshana Pushpakumara, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 56
Dengue and COVID-19: two sides of the same coin
Gathsaurie Neelika Malavige, Chandima Jeewandara, Graham S. Ogg
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 35
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 31
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1972-1972
Open Access | Times Cited: 33
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
Julia Castro, Patrick O. Azevedo, Marcílio Jorge Fumagalli, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
Constant Gillot, Julien Favresse, Clara David, et al.
Microbiology Research (2024) Vol. 15, Iss. 1, pp. 422-430
Open Access | Times Cited: 5
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
Javier Castillo‐Olivares, David A. Wells, Matteo Ferrari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32
kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers
José F. Varona, Rodrigo Madurga, Francisco Peñalver, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 97-103
Open Access | Times Cited: 30
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
Mihaela Zlei, Igor A. Sidorov, Simone A. Joosten, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2743-2743
Open Access | Times Cited: 20
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
Chandima Jeewandara, Dinuka Guruge, Pradeep Darshana Pushpakumara, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
Adin Sejdic, Anders Frische, Charlotte Sværke Jørgensen, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108572-108572
Open Access | Times Cited: 10
The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in Sri Lankan children and association with the nutritional status
Chandima Jeewandara, Maneshka Vindesh Karunananda, Suranga Fernando, et al.
Research Square (Research Square) (2025)
Closed Access
Explaining Racial and Ethnic Inequities in SARS-CoV-2-Related Outcomes: Results from a Serosurvey in Chicago
Catherine Eyo, Joshua M. Schrock, Christina Hayford, et al.
Journal of Racial and Ethnic Health Disparities (2025)
Closed Access
Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients
Achala Kamaladasa, Banuri Gunasekara, Chandima Jeewandara, et al.
International Journal of Infectious Diseases (2021) Vol. 109, pp. 85-89
Open Access | Times Cited: 22
Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease
Javier Castillo‐Olivares, David A. Wells, Matteo Ferrari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 263-274
Open Access | Times Cited: 14
Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico
Miguel A. Fernández‐Rojas, Marco A. Luna-Ruiz Esparza, Abraham Campos‐Romero, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 275-285
Open Access | Times Cited: 13
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study
Amelia Sancilio, Joshua M. Schrock, Alexis R. Demonbreun, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection
Ellie Ivanova, Joseph C. Devlin, Terkild B. Buus, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 17
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS-CoV-2 Spike protein after natural infection or COVID-19 vaccination
Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top